Last Updated: September 24, 2026

ORUVAIL Drug Patent Profile

Name: ORUVAIL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Oruvail, and what generic alternatives are available?

Oruvail is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in ORUVAIL is ketoprofen. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Oruvail

A generic version of ORUVAIL was approved as ketoprofen by TEVA on December 22^nd, 1992.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ORUVAIL?
What are the global sales for ORUVAIL?
What is Average Wholesale Price for ORUVAIL?

Summary for ORUVAIL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	2
Patent Applications:	557
DailyMed Link:	ORUVAIL at DailyMed

Drug patent expirations by year for ORUVAIL

Recent Clinical Trials for ORUVAIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Rochester	Phase 2/Phase 3
Mae Stone Goode Foundation	Phase 2/Phase 3
Sanford Research	Early Phase 1

See all ORUVAIL clinical trials

US Patents and Regulatory Information for ORUVAIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	ORUVAIL	ketoprofen	CAPSULE, EXTENDED RELEASE;ORAL	019816-003	Feb 8, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Pharms Inc	ORUVAIL	ketoprofen	CAPSULE, EXTENDED RELEASE;ORAL	019816-002	Feb 8, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Pharms Inc	ORUVAIL	ketoprofen	CAPSULE, EXTENDED RELEASE;ORAL	019816-001	Sep 24, 1993		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.